Surge Therapeutics

Focused. Immunotherapy. Delivered.

Cambridge, United States · Founded 2018 · $58.0M raised

Employees
1–10
Founded
2018
Business Model
B2B
Total Funding
$58.0M
Last Round
$32.0M Series BJul 2023
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

SURGE develops a biodegradable hydrogel injected into the site of surgical tumor resection to extend the local release of cancer immunotherapy. Its approach seeks to help cancer patients undergoing tumor surgery prevent post-surgical recurrence and metastasis. Built on research at Harvard Medical School, the company aims to translate intraoperative immunotherapy to patients and transform the standard of care for cancer surgery.

Summary

Surge Therapeutics is a Biotech company based in Cambridge, United States, founded in 2018. It has raised $58.0M in total across 2 rounds, most recently a $32.0M Series B round in Jul 2023. Investors include Camford Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJul 2023
$32.0M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Mirador Therapeutics

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

San Diego, United States11–50Biotech, Drug Discovery
Series BTotal funding$650.0MOct 2025
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series BTotal funding$612.0MOct 2022
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Surge Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/surge-therapeutics"><img src="https://indexed.vc/api/badge/company/surge-therapeutics" alt="Surge Therapeutics on Indexed.vc" width="260" height="76" /></a>